Cargando…
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An In-Vitro Study of Tenogenic Events on Wharton’s Jelly Mesenchymal Stem Cells
The present work described a bio-functionalized 3D fibrous construct, as an interactive teno-inductive graft model to study tenogenic potential events of human mesenchymal stem cells collected from Wharton’s Jelly (hWJ-MSCs). The 3D-biomimetic and bioresorbable scaffold was functionalized with nanoc...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465418/ https://www.ncbi.nlm.nih.gov/pubmed/34575523 http://dx.doi.org/10.3390/pharmaceutics13091448 |
_version_ | 1784572868380590080 |
---|---|
author | Ciardulli, Maria Camilla Lovecchio, Joseph Scala, Pasqualina Lamparelli, Erwin Pavel Dale, Tina Patricia Giudice, Valentina Giordano, Emanuele Selleri, Carmine Forsyth, Nicholas Robert Maffulli, Nicola Della Porta, Giovanna |
author_facet | Ciardulli, Maria Camilla Lovecchio, Joseph Scala, Pasqualina Lamparelli, Erwin Pavel Dale, Tina Patricia Giudice, Valentina Giordano, Emanuele Selleri, Carmine Forsyth, Nicholas Robert Maffulli, Nicola Della Porta, Giovanna |
author_sort | Ciardulli, Maria Camilla |
collection | PubMed |
description | The present work described a bio-functionalized 3D fibrous construct, as an interactive teno-inductive graft model to study tenogenic potential events of human mesenchymal stem cells collected from Wharton’s Jelly (hWJ-MSCs). The 3D-biomimetic and bioresorbable scaffold was functionalized with nanocarriers for the local controlled delivery of a teno-inductive factor, i.e., the human Growth Differentiation factor 5 (hGDF-5). Significant results in terms of gene expression were obtained. Namely, the up-regulation of Scleraxis (350-fold, p ≤ 0.05), type I Collagen (8-fold), Decorin (2.5-fold), and Tenascin-C (1.3-fold) was detected at day 14; on the other hand, when hGDF-5 was supplemented in the external medium only (in absence of nanocarriers), a limited effect on gene expression was evident. Teno-inductive environment also induced pro-inflammatory, (IL-6 (1.6-fold), TNF (45-fold, p ≤ 0.001), and IL-12A (1.4-fold)), and anti-inflammatory (IL-10 (120-fold) and TGF-β1 (1.8-fold)) cytokine expression upregulation at day 14. The presented 3D construct opens perspectives for the study of drug controlled delivery devices to promote teno-regenerative events. |
format | Online Article Text |
id | pubmed-8465418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84654182021-09-27 3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An In-Vitro Study of Tenogenic Events on Wharton’s Jelly Mesenchymal Stem Cells Ciardulli, Maria Camilla Lovecchio, Joseph Scala, Pasqualina Lamparelli, Erwin Pavel Dale, Tina Patricia Giudice, Valentina Giordano, Emanuele Selleri, Carmine Forsyth, Nicholas Robert Maffulli, Nicola Della Porta, Giovanna Pharmaceutics Article The present work described a bio-functionalized 3D fibrous construct, as an interactive teno-inductive graft model to study tenogenic potential events of human mesenchymal stem cells collected from Wharton’s Jelly (hWJ-MSCs). The 3D-biomimetic and bioresorbable scaffold was functionalized with nanocarriers for the local controlled delivery of a teno-inductive factor, i.e., the human Growth Differentiation factor 5 (hGDF-5). Significant results in terms of gene expression were obtained. Namely, the up-regulation of Scleraxis (350-fold, p ≤ 0.05), type I Collagen (8-fold), Decorin (2.5-fold), and Tenascin-C (1.3-fold) was detected at day 14; on the other hand, when hGDF-5 was supplemented in the external medium only (in absence of nanocarriers), a limited effect on gene expression was evident. Teno-inductive environment also induced pro-inflammatory, (IL-6 (1.6-fold), TNF (45-fold, p ≤ 0.001), and IL-12A (1.4-fold)), and anti-inflammatory (IL-10 (120-fold) and TGF-β1 (1.8-fold)) cytokine expression upregulation at day 14. The presented 3D construct opens perspectives for the study of drug controlled delivery devices to promote teno-regenerative events. MDPI 2021-09-10 /pmc/articles/PMC8465418/ /pubmed/34575523 http://dx.doi.org/10.3390/pharmaceutics13091448 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ciardulli, Maria Camilla Lovecchio, Joseph Scala, Pasqualina Lamparelli, Erwin Pavel Dale, Tina Patricia Giudice, Valentina Giordano, Emanuele Selleri, Carmine Forsyth, Nicholas Robert Maffulli, Nicola Della Porta, Giovanna 3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An In-Vitro Study of Tenogenic Events on Wharton’s Jelly Mesenchymal Stem Cells |
title | 3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An In-Vitro Study of Tenogenic Events on Wharton’s Jelly Mesenchymal Stem Cells |
title_full | 3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An In-Vitro Study of Tenogenic Events on Wharton’s Jelly Mesenchymal Stem Cells |
title_fullStr | 3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An In-Vitro Study of Tenogenic Events on Wharton’s Jelly Mesenchymal Stem Cells |
title_full_unstemmed | 3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An In-Vitro Study of Tenogenic Events on Wharton’s Jelly Mesenchymal Stem Cells |
title_short | 3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An In-Vitro Study of Tenogenic Events on Wharton’s Jelly Mesenchymal Stem Cells |
title_sort | 3d biomimetic scaffold for growth factor controlled delivery: an in-vitro study of tenogenic events on wharton’s jelly mesenchymal stem cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465418/ https://www.ncbi.nlm.nih.gov/pubmed/34575523 http://dx.doi.org/10.3390/pharmaceutics13091448 |
work_keys_str_mv | AT ciardullimariacamilla 3dbiomimeticscaffoldforgrowthfactorcontrolleddeliveryaninvitrostudyoftenogeniceventsonwhartonsjellymesenchymalstemcells AT lovecchiojoseph 3dbiomimeticscaffoldforgrowthfactorcontrolleddeliveryaninvitrostudyoftenogeniceventsonwhartonsjellymesenchymalstemcells AT scalapasqualina 3dbiomimeticscaffoldforgrowthfactorcontrolleddeliveryaninvitrostudyoftenogeniceventsonwhartonsjellymesenchymalstemcells AT lamparellierwinpavel 3dbiomimeticscaffoldforgrowthfactorcontrolleddeliveryaninvitrostudyoftenogeniceventsonwhartonsjellymesenchymalstemcells AT daletinapatricia 3dbiomimeticscaffoldforgrowthfactorcontrolleddeliveryaninvitrostudyoftenogeniceventsonwhartonsjellymesenchymalstemcells AT giudicevalentina 3dbiomimeticscaffoldforgrowthfactorcontrolleddeliveryaninvitrostudyoftenogeniceventsonwhartonsjellymesenchymalstemcells AT giordanoemanuele 3dbiomimeticscaffoldforgrowthfactorcontrolleddeliveryaninvitrostudyoftenogeniceventsonwhartonsjellymesenchymalstemcells AT sellericarmine 3dbiomimeticscaffoldforgrowthfactorcontrolleddeliveryaninvitrostudyoftenogeniceventsonwhartonsjellymesenchymalstemcells AT forsythnicholasrobert 3dbiomimeticscaffoldforgrowthfactorcontrolleddeliveryaninvitrostudyoftenogeniceventsonwhartonsjellymesenchymalstemcells AT maffullinicola 3dbiomimeticscaffoldforgrowthfactorcontrolleddeliveryaninvitrostudyoftenogeniceventsonwhartonsjellymesenchymalstemcells AT dellaportagiovanna 3dbiomimeticscaffoldforgrowthfactorcontrolleddeliveryaninvitrostudyoftenogeniceventsonwhartonsjellymesenchymalstemcells |